Biotechnology Law Report

Papers
(The H4-Index of Biotechnology Law Report is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
CareDx, Inc. v. Natera, Inc. United States Court of Appeals of the Federal Circuit, 2022 40 F.4th 137117
The Localization of Drug Patent Linkage System in China: Where Should It Go?4
Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines4
Trade Secret Protection on a Publicly Sold, Patented Spinal Implant Device: Life Spine, Inc. v. Aegis Spine, Inc.3
Legal Governance of Human Gene Editing Technology: From Single Governance to Multiple Governance3
To What Extent Does Mayo v. Prometheus Allow for the Patenting of Diagnostic Methods?3
0.20437908172607